{"id":531074,"date":"2021-02-20T19:02:01","date_gmt":"2021-02-20T19:02:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=531074"},"modified":"2021-02-20T19:02:01","modified_gmt":"2021-02-20T19:02:01","slug":"sarcoidosis-market-research-report-epidemiology-and-competitive-insights-2030-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/sarcoidosis-market-research-report-epidemiology-and-competitive-insights-2030-by-delveinsight_531074.html","title":{"rendered":"Sarcoidosis Market Research Report, Epidemiology, and Competitive Insights 2030 by DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1613720697.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Sarcoidosis Market Research Report, Epidemiology, and Competitive Insights 2030 by DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1613720697.jpeg\" alt=\"Sarcoidosis Market Research Report, Epidemiology, and Competitive Insights 2030 by DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Sarcoidosis &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221; report delivers an in-depth understanding of the Sarcoidosis, historical and forecasted epidemiology as well as the Sarcoidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<\/div>\n<p style=\"text-align: justify;\">DelveInisght launched a new report on <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/sarcoidosis-market?utm_source=ABnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">Sarcoidosis Market Insights, Epidemiology and Market Forecast 2030<\/a><\/strong>.<\/p>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s &#8220;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/sarcoidosis-market?utm_source=ABnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\"><strong>Sarcoidosis Market Insights, Epidemiology, and Market Forecast-2030<\/strong><\/a>&#8221;&nbsp;report delivers an in-depth understanding of the Sarcoidosis, historical and forecasted epidemiology as well as the Sarcoidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/dfddeff145bd829dea3bdd0a81b2821f.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\"><strong>Sarcoidosis<\/strong>, also known as the Besnier-Boeck-Schaumann disease,is a multi-system disorder of unclear etiology, typically affecting the lymphatic system and the lungs. The presence of non-caseating granuloma is the histopathological hallmark of the disease. The clinical course of the disease can range from an acute self-limited process to progressive organ dysfunction with significant morbidity and mortality. Sarcoidosis is generally categorized into <strong>two subgroups:<\/strong> <strong>intra-thoracic and extra-thoracic<\/strong>, based on the site of involvement.<\/p>\n<p style=\"text-align: justify;\"><strong>&#8220;The prevalence of Sarcoidosis is generally higher among the female population as compared to males.&#8221;<\/strong><\/p>\n<p style=\"text-align: justify;\">A study conducted by Orianne Dumas <em>et.al.<\/em> titled, &ldquo;Epidemiology of Sarcoidosis in a Prospective Cohort Study of U.S. Women&rdquo;, reported that the baseline prevalence was 100\/100,000 women, while the average annual incidence rate was 11\/100,000 during 2,275,028 person-years of follow up<\/p>\n<p style=\"text-align: justify;\"><strong>Request for a detailed sample copy of the report:&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/sarcoidosis-market?utm_source=ABnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\"><span data-sheets-value=\"{\" data-sheets-userformat=\"{\">https:\/\/www.delveinsight.com\/sample-request\/sarcoidosis-market<\/span><\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/sarcoidosis-market?utm_source=ABnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\"><strong>Table of contents<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">1 Key Insight<br \/> 2 Executive Summary of Sarcoidosis<br \/> 3 Sarcoidosis Market Overview at a Glance<br \/> 4 Disease Background and Overview: Sarcoidosis<br \/> 5 Case Reports<br \/> 6 Sarcoidosis Epidemiology and Patient Population<br \/> 7 United States Epidemiology<br \/> 8 EU5 Epidemiology<br \/> 9 Japan Epidemiology<br \/> 10 Current Sarcoidosis Treatment and Medical Practices<br \/> 11 Unmet needs<br \/> 12 Sarcoidosis Marketed Drugs<br \/> 13 Sarcoidosis Emerging Drugs<br \/> 14 Sarcoidosis 7MM Market Analysis<br \/> 15 United States<br \/> 16 EU-5 countries: Market Outlook<br \/> 17 Japan Market Outlook<br \/> 18 Sarcoidosis Market Drivers<br \/> 19 Sarcoidosis Market Barriers<br \/> 20 SWOT Analysis<br \/> 21 Reimbursement and market access<br \/> 22 Appendix<br \/> 23 DelveInsight Capabilities<br \/> 24 Disclaimer<br \/> 25 About DelveInsight<\/p>\n<p style=\"text-align: justify;\"><strong>Download report:&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/sarcoidosis-market?utm_source=ABnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\"><span data-sheets-value=\"{\" data-sheets-userformat=\"{\" data-mce-mark=\"1\">https:\/\/www.delveinsight.com\/report-store\/sarcoidosis-market<\/span><\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>About DelveInsight<\/strong><br \/> DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56431.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=sarcoidosis-market-research-report-epidemiology-and-competitive-insights-2030-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=sarcoidosis-market-research-report-epidemiology-and-competitive-insights-2030-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight Business Research LLP DelveInsight&#8217;s &#8220;Sarcoidosis &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221; report delivers an in-depth understanding of the Sarcoidosis, historical and forecasted epidemiology as well as the Sarcoidosis market trends in the United States, EU5 (Germany, Spain, Italy, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/sarcoidosis-market-research-report-epidemiology-and-competitive-insights-2030-by-delveinsight_531074.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-531074","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/531074","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=531074"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/531074\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=531074"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=531074"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=531074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}